#METABOLOMICS WORKBENCH philmus_lab_20200728_134003 DATATRACK_ID:2105 STUDY_ID:ST001436 ANALYSIS_ID:AN002399 PROJECT_ID:PR000987
VERSION             	1
CREATED_ON             	July 30, 2020, 5:12 pm
#PROJECT
PR:PROJECT_TITLE                 	Gut microbiota mediates the interplay between immunity and glucose metabolism
PR:PROJECT_TYPE                  	preclinical studies
PR:PROJECT_SUMMARY               	Diabetes, obesity and metabolic disease have reached epidemic proportions. Much
PR:PROJECT_SUMMARY               	research on these diseases has focused on tissues such as adipose, liver, muscle
PR:PROJECT_SUMMARY               	and pancreas. The role of the gut in glucose metabolism is relatively unstudied;
PR:PROJECT_SUMMARY               	however, it can also have a significant effect on systemic glucose control.
PR:PROJECT_SUMMARY               	Residing in the gut is a complex community of microbes, termed microbiota, which
PR:PROJECT_SUMMARY               	are important contributors to immunity and metabolism, frequently mediating
PR:PROJECT_SUMMARY               	cross-talks between these two functions. Changes in the gut microbiota of type 2
PR:PROJECT_SUMMARY               	diabetes (T2D) patients are directly linked to metabolic dysregulation in the
PR:PROJECT_SUMMARY               	disease. Therefore, the goal of the project is to identify and test microbes and
PR:PROJECT_SUMMARY               	microbial factors involved in regulation of glucose metabolism. For this,
PR:PROJECT_SUMMARY               	microbiota perturbation by western diet followed by global analyses of gut
PR:PROJECT_SUMMARY               	microbiome and host transcriptome combined with causal inference analysis is
PR:PROJECT_SUMMARY               	employed. Newly inferred probiotics are tested in mice fed with western diet
PR:PROJECT_SUMMARY               	followed by metabolomics analysis. This research provides a mechanistic
PR:PROJECT_SUMMARY               	explanation of how probiotics helps disclose mechanisms of T2D as well as will
PR:PROJECT_SUMMARY               	identify protective microbial factors for development of therapy of diabetes.
PR:INSTITUTE                     	Oregon State University
PR:DEPARTMENT                    	Pharmaceutical Sciences
PR:LABORATORY                    	Morgun and Shulzhenko
PR:LAST_NAME                     	Andriy
PR:FIRST_NAME                    	Morgun
PR:ADDRESS                       	203 Pharmacy Bldg, Corvallis, OR 97331
PR:EMAIL                         	andriy.morgun@oregonstate.edu
PR:PHONE                         	1 541 737 8047
PR:FUNDING_SOURCE                	NIH R01 DK103761
#STUDY
ST:STUDY_TITLE                   	Transkingdom interactions between Lactobacilli and hepatic mitochondria
ST:STUDY_TITLE                   	attenuate western diet induced diabetes
ST:STUDY_TYPE                    	Supplementation of mice with probiotic bacteria
ST:STUDY_SUMMARY                 	For WD + Microbes 1 and WD + Microbes 3 experiments, C57BL/6 mice were fed
ST:STUDY_SUMMARY                 	western diet or western diet supplemented with Lactobacillus gasseri or
ST:STUDY_SUMMARY                 	Lactobacillus johnsonii for 8 weeks and serum was collected from each mice. For
ST:STUDY_SUMMARY                 	Pooled_1 (control group, western diet only), and Pooled_2 (western diet +
ST:STUDY_SUMMARY                 	Lactobacillus gasseri) groups, serum from 5 mice each was pooled. For Pooled_3
ST:STUDY_SUMMARY                 	(western diet + Lactobacillus johnsonii) group, serum from 4 mice was pooled.
ST:STUDY_SUMMARY                 	For Pooled_7 (control group, western diet only), Pooled_8 (western diet +
ST:STUDY_SUMMARY                 	Lactobacillus gasseri) and Pooled_9 (western diet + Lactobacillus johnsonii)
ST:STUDY_SUMMARY                 	groups, serum from 6 mice each was pooled. For WD + Microbes 6 experiment,
ST:STUDY_SUMMARY                 	C57BL/6 mice were fed western diet for 8 weeks. Then, one group (n = 5) of mice
ST:STUDY_SUMMARY                 	was supplemented with Lactobacillus gasseri for 12 weeks along with continuation
ST:STUDY_SUMMARY                 	of western diet and serum was collected. For Pooled_10 (control group, western
ST:STUDY_SUMMARY                 	diet only) and Pooled_11 (western diet + Lactobacillus gasseri) groups, serum
ST:STUDY_SUMMARY                 	from 5 mice each was pooled. For GF + WD + LG experiment, C57BL/6 germ free mice
ST:STUDY_SUMMARY                 	were fed western diet or western diet supplemented with Lactobacillus gasseri
ST:STUDY_SUMMARY                 	for 2 weeks. For Pooled_12 (control, western diet only) and Pooled_13 (western
ST:STUDY_SUMMARY                 	diet + Lactobacillus gasseri) groups, serum from 2 mice each was pooled.
ST:INSTITUTE                     	Oregon State University
ST:DEPARTMENT                    	Pharmaceutical Sciences
ST:LABORATORY                    	Morgun and Shulzhenko
ST:LAST_NAME                     	Morgun
ST:FIRST_NAME                    	Andriy
ST:ADDRESS                       	203 Pharmacy Bldg
ST:EMAIL                         	andriy.morgun@oregonstate.edu
ST:PHONE                         	1 541 737 8047
ST:NUM_GROUPS                    	7
#SUBJECT
SU:SUBJECT_TYPE                  	Mammal
SU:SUBJECT_SPECIES               	Mus musculus
SU:TAXONOMY_ID                   	10090
SU:GENOTYPE_STRAIN               	C57Bl/6
SU:AGE_OR_AGE_RANGE              	10-20 weeks
SU:GENDER                        	Male
#SUBJECT_SAMPLE_FACTORS:         	SUBJECT(optional)[tab]SAMPLE[tab]FACTORS(NAME:VALUE pairs separated by |)[tab]Raw file names and additional sample data
SUBJECT_SAMPLE_FACTORS           	-	Sample_01	Treatment:Western diet	Genotype=Wild-type, Specific pathogen free; RAW_FILE_NAME=Sample-pos_01.d; RAW_FILE_NAME=Sample-neg_01.d
SUBJECT_SAMPLE_FACTORS           	-	Sample_02	Treatment:Western diet + Lactobacillus gasseri	Genotype=Wild-type, Specific pathogen free; RAW_FILE_NAME=Sample-pos_02.d; RAW_FILE_NAME=Sample-neg_02.d
SUBJECT_SAMPLE_FACTORS           	-	Sample_03	Treatment:Western diet + Lactobacillus johnsonii	Genotype=Wild-type, Specific pathogen free; RAW_FILE_NAME=Sample-pos_03.d; RAW_FILE_NAME=Sample-neg_03.d
SUBJECT_SAMPLE_FACTORS           	-	Sample_07	Treatment:Western diet	Genotype=Wild-type, Specific pathogen free; RAW_FILE_NAME=Sample-pos_07.d; RAW_FILE_NAME=Sample-neg_07.d
SUBJECT_SAMPLE_FACTORS           	-	Sample_08	Treatment:Western diet + Lactobacillus gasseri	Genotype=Wild-type, Specific pathogen free; RAW_FILE_NAME=Sample-pos_08.d; RAW_FILE_NAME=Sample-neg_08.d
SUBJECT_SAMPLE_FACTORS           	-	Sample_09	Treatment:Western diet + Lactobacillus johnsonii	Genotype=Wild-type, Specific pathogen free; RAW_FILE_NAME=Sample-pos_09.d; RAW_FILE_NAME=Sample-neg_09.d
SUBJECT_SAMPLE_FACTORS           	-	Sample_10	Treatment:Western diet	Genotype=Wild-type, Specific pathogen free; RAW_FILE_NAME=Sample-pos_10.d; RAW_FILE_NAME=Sample-neg_10.d
SUBJECT_SAMPLE_FACTORS           	-	Sample_11	Treatment:Western diet + Lactobacillus gasseri	Genotype=Wild-type, Specific pathogen free; RAW_FILE_NAME=Sample-pos_11.d; RAW_FILE_NAME=Sample-neg_11.d
SUBJECT_SAMPLE_FACTORS           	-	Sample_12	Treatment:Western diet	Genotype=Wild-type, Germ free; RAW_FILE_NAME=Sample-pos_12.d; RAW_FILE_NAME=Sample-neg_12.d
SUBJECT_SAMPLE_FACTORS           	-	Sample_13	Treatment:Western diet + Lactobacillus gasseri	Genotype=Wild-type, Germ free; RAW_FILE_NAME=Sample-pos_13.d; RAW_FILE_NAME=Sample-neg_13.d
#COLLECTION
CO:COLLECTION_SUMMARY            	After the end of the experiment, whole blood was collected in BD Microtainer
CO:COLLECTION_SUMMARY            	Serum Separator Tube and allowed to clot by leaving undistubred at room
CO:COLLECTION_SUMMARY            	temperature for 30 minutes. Then the tubes were centrifuged at 2000 x g for 10
CO:COLLECTION_SUMMARY            	minutes in 4°C and the supernatant was immediately transferred into a
CO:COLLECTION_SUMMARY            	polypropylene tube and stored at -80°C until further analysis.
CO:SAMPLE_TYPE                   	Blood (serum)
CO:STORAGE_CONDITIONS            	-80℃
#TREATMENT
TR:TREATMENT_SUMMARY             	Western diet fed mice were supplemented with Lactobacillus gasseri or
TR:TREATMENT_SUMMARY             	Lactobacillus johnsonii. For control groups, equal volume of vehicle (PBS) was
TR:TREATMENT_SUMMARY             	gavaged. Supplementation was done for 2 to 8 weeks.
#SAMPLEPREP
SP:SAMPLEPREP_SUMMARY            	Metabolites were extracted with 4 volumes of cold methanol/acetonitrile (1:1,
SP:SAMPLEPREP_SUMMARY            	v/v). To precipitate proteins, the samples were incubated for 1h at -20°C.
SP:SAMPLEPREP_SUMMARY            	After the samples were centrifuged at 4°C for 15 min at 13,000 rpm, the
SP:SAMPLEPREP_SUMMARY            	supernatant was collected and evaporated to dryness in a vacuum concentrator.
SP:SAMPLEPREP_SUMMARY            	The dry extracts were then reconstituted in 90 μL of acetonitrile/H2O (1:1,
SP:SAMPLEPREP_SUMMARY            	v/v) containing 10 ng/mL CUDA (12-[[(cyclohexylamino)carbonyl] amino]-dodecanoic
SP:SAMPLEPREP_SUMMARY            	acid).
#CHROMATOGRAPHY
CH:CHROMATOGRAPHY_TYPE           	Reversed phase
CH:INSTRUMENT_NAME               	Agilent 1290 Infinity
CH:COLUMN_NAME                   	Poroshell EC-C18 (100 x 3.0 mm, 2.7 um)
CH:FLOW_RATE                     	0.4 ml/min
CH:COLUMN_TEMPERATURE            	40
#ANALYSIS
AN:ANALYSIS_TYPE                 	MS
#MS
MS:INSTRUMENT_NAME               	Agilent 6545 QToF
MS:INSTRUMENT_TYPE               	QTOF
MS:MS_TYPE                       	ESI
MS:ION_MODE                      	POSITIVE
MS:MS_COMMENTS                   	None
MS:MS_RESULTS_FILE               	ST001436_AN002399_Results.txt	UNITS:AUC	Has m/z:Yes	Has RT:Yes	RT units:Minutes
#END